Table 1 Clinical and radiological features of marginal zone lymphoma patients
From: Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases
Case no. | Age/sex | Location(s) | Radiology | Treatment | Remission/ outcome | Duration of PR/CR (months) |
|---|---|---|---|---|---|---|
1 | 40/F | Cavernous sinus | Mass | RT | CR/ANED | 63 |
2 | 62/F | Parietal, bilateral | Thickening | Fludarabine | CR/ANED | 22 |
3 | 52/F | Frontal | Mass | RT, MTX, ARA-C | CR/ANED | 7 |
4 | 43/F | Tentorium | Mass | RT | CR/ANED | 9 |
5 | 57/F | Anterior falcine | Mass | RT | CR/ANED | 14 |
6 | 37/F | Not known | Mass | |||
7 | 44/M | Frontal | Thickening | |||
8 | 53/M | Posterior fossa, bilateral | Mass | None | CR/ANED | 17 |
9 | 42/F | Not known | Unknown | |||
10 | 53/M | Parietal | Lytic bone lesion | RT | CR/ANED | 36 |
11 | 47/F | Not known | Mass | |||
12 | 46/F | Cavernous sinus | Mass | RT | CR/ANED | 62 |
13 | 59/F | Tentorium | Mass | |||
14a | 61/F | Posterior fossa | Thickening | Steroids | CR/ANED | 5 |
15 | 45/F | Frontal | Mass | Observation | CR/ANED | 4 |
16 | 48/F | Frontal | Mass | |||
17 | 57/F | Fronto-temporal, multiple | Mass | RT, steroids, rituxan | CR/ANED | 5 |
18 | 50/F | Not known | Mass | |||
19 | 66/F | Frontal | Mass | |||
20 | 44/F | Temporal | Mass | |||
21 | 73/F | Not known | Mass | |||
22 | 56/F | Occipital | Mass | RT, steroids | CR/ANED | 30 |
23 | 31/F | Not known | Unknown | |||
24 | 71/M | Parietal | Mass | Observation | CR/ANED | 16 |
25 | 42/F | Occipital | Mass | ?RT | PR/AWD | 6 |
26 | 40/F | Middle cranial fossa | Mass | |||
27 | 42/F | Parieto-temporal | Mass | RT, MTX | CR/ANED | 96 |
28 | 36/F | Thoracic spine | Mass, epidural | |||
Cases with associated extradural disease | ||||||
29 | 52/M | Parietal | Mass | RT | CR/ANED | 36 |
30 | 45/F | Temporal | Mass | None | CR/ANED | 124 |
31 | 51/F | Not known | Mass | |||
32 | 50/F | Parietal | Thickening | |||
